Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia : cardiovascular topics

This publication has 39 references indexed in Scilit:

• Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?
  CardioVascular Journal of Africa, 2011
• Do pregnancies with pre‐eclampsia have smaller placentas? A population study of 317 688 pregnancies with and without growth restriction in the offspring
  BJOG: An International Journal of Obstetrics & Gynaecology, 2010
• Soluble endoglin and transforming growth factor‐β1 in women who subsequently developed preeclampsia
  Prenatal Diagnosis, 2009
• A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
  The Journal of Maternal-Fetal & Neonatal Medicine, 2008
• Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia
  Nephrology Dialysis Transplantation, 2007
• Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule
  Nephrology Dialysis Transplantation, 2006
• Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
  New England Journal of Medicine, 2006
• Does Human Immunodeficiency Virus Infection Protect Against Preeclampsia-Eclampsia?
  Obstetrics & Gynecology, 2004
• Pre-eclampsia, antiretroviral therapy, and immune reconstitution
  The Lancet, 2002
• Transforming growth factor‐beta 1 serum levels in pregnancy and pre‐eclampsia
  Acta Obstetricia et Gynecologica Scandinavica, 2002